Novozymes A/S (NSIS-B.CO) stock analysis

In our weekly check, Novozymes A/S is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 17 pass, warnings: 6, red flags: 2.

About Novozymes A/S

Novozymes A/S is a Basic Materials company (Chemicals - Specialty) based in Denmark, listed on CPH as NSIS-B.CO.

What our checks show for NSIS-B.CO

Red flags

• The net margin fell by 6.3 points over 5 years, to 14.7%: the company keeps less of each sale as profit.
• The share count grew by 49.6% in 2 years: each shareholder owns a smaller slice.

Warning signs

• The gross margin fell by 2.8 points, to 54.9%: costs are rising faster than prices.
• Earnings per share fell 7.7% a year over the last 3 years.
• The price is 46 times earnings (P/E): the market already pays for a lot of future growth.
• The stock has fallen as much as 53% from a peak. Would you have held through that?
• Recovering from its deepest fall took about 1.7 years.
• Return on capital (ROCE) is only 5.9%.

Strengths

• Operating profit covers interest 10.9 times over.
• Operating cash flow is 2.09x net profit: the profit arrives as real cash.
• Analysts expect earnings per share to grow about 29.1% a year over the next years.
• Analysts expect the net margin to improve by 8.9 points from today's 14.7%.
• Revenue grew 22.2% a year over the last 3 years.
• Free cash flow is 19% of revenue: cash for dividends, buybacks or growth.

Next earnings report: 2026-11-05

Similar companies

LIN · AI.PA · 1301.TW · SHW · ECL · APD

Questions

What grade does Novozymes A/S (NSIS-B.CO) have?

In our weekly check, Novozymes A/S is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 17 pass, warnings: 6, red flags: 2. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of NSIS-B.CO stock?

This week's biggest flags for Novozymes A/S: Margins falling, Share dilution, Gross margin falling. In total 8 of 25 checks show a warning or a red flag.

What does Novozymes A/S do?

Novozymes A/S is a Basic Materials company (Chemicals - Specialty) based in Denmark, listed on CPH as NSIS-B.CO.

When does Novozymes A/S report earnings next?

The next earnings report is expected on 2026-11-05. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-24

Open the full analysis